497 related articles for article (PubMed ID: 32281032)
21. Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life.
Eikeland SA; Smeland KB; Mols F; Fagerli UM; Bersvendsen HS; Kiserud CE; Fosså A
Acta Oncol; 2021 Jul; 60(7):911-920. PubMed ID: 33905285
[TBL] [Abstract][Full Text] [Related]
22. Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors.
Galantino ML; Tiger R; Brooks J; Jang S; Wilson K
Integr Cancer Ther; 2019; 18():1534735419850627. PubMed ID: 31131640
[TBL] [Abstract][Full Text] [Related]
23. Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study.
Engvall K; Gréen H; Fredrikson M; Lagerlund M; Lewin F; Åvall-Lundqvist E
Breast Cancer Res Treat; 2022 Oct; 195(3):379-391. PubMed ID: 35941422
[TBL] [Abstract][Full Text] [Related]
24. The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry.
Beijers AJ; Oerlemans S; Mols F; Eurelings M; Minnema MC; Vreugdenhil A; van de Poll-Franse LV
Ann Hematol; 2017 Apr; 96(4):653-663. PubMed ID: 28116479
[TBL] [Abstract][Full Text] [Related]
25. The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study.
McNeish BL; Dittus K; Mossburg J; Krant N; Steinharter JA; Feb K; Cote H; Hehir MK; Reynolds R; Redfern MS; Rosano C; Richardson JK; Kolb N
J Geriatr Oncol; 2024 May; 15(4):101765. PubMed ID: 38581957
[TBL] [Abstract][Full Text] [Related]
26. Older ovarian cancer survivors report lower long-term health-related quality of life than younger survivors: A study from the population-based profiles registry.
van Walree IC; Hamaker ME; van de Poll-Franse LV; Vos MC; Boll D; van Huis-Tanja LH; Ezendam NPM
Gynecol Oncol; 2019 May; 153(2):391-398. PubMed ID: 30772033
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal Associations of Sedentary Behavior and Physical Activity with Quality of Life in Colorectal Cancer Survivors.
Kenkhuis MF; VAN Roekel EH; Breedveld-Peters JJL; Breukink SO; Janssen-Heijnen MLG; Keulen ETP; VAN Duijnhoven FJB; Mols F; Weijenberg MP; Bours MJL
Med Sci Sports Exerc; 2021 Nov; 53(11):2298-2308. PubMed ID: 34033619
[TBL] [Abstract][Full Text] [Related]
28. Treatment-related differences in health related quality of life and disease specific symptoms among colon cancer survivors: results from the population-based PROFILES registry.
Verhaar S; Vissers PA; Maas H; van de Poll-Franse LV; van Erning FN; Mols F
Eur J Cancer; 2015 Jul; 51(10):1263-73. PubMed ID: 25953068
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).
Cheng HL; Molassiotis A
Asia Pac J Clin Oncol; 2019 Feb; 15(1):56-62. PubMed ID: 29873180
[TBL] [Abstract][Full Text] [Related]
30. Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial.
Teran-Wodzinski P; Haladay D; Vu T; Ji M; Coury J; Adams A; Schwab L; Visovsky C
Trials; 2022 Apr; 23(1):363. PubMed ID: 35477489
[TBL] [Abstract][Full Text] [Related]
31. Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy.
Knoerl R; Gray E; Stricker C; Mitchell SA; Kippe K; Smith G; Dudley WN; Lavoie Smith EM
Support Care Cancer; 2017 Nov; 25(11):3437-3446. PubMed ID: 28577231
[TBL] [Abstract][Full Text] [Related]
32. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL;
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828
[TBL] [Abstract][Full Text] [Related]
33. Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy.
Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB
Gait Posture; 2021 Sep; 89():178-185. PubMed ID: 34320441
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel.
Ventzel L; Jensen AB; Jensen AR; Jensen TS; Finnerup NB
Pain; 2016 Mar; 157(3):560-568. PubMed ID: 26529271
[TBL] [Abstract][Full Text] [Related]
35. Exploring the relationship among dispositional optimism, health-related quality of life, and CIPN severity among colorectal cancer patients with chronic peripheral neuropathy.
Trompetter HR; Bonhof CS; van de Poll-Franse LV; Vreugdenhil G; Mols F
Support Care Cancer; 2022 Jan; 30(1):95-104. PubMed ID: 34232392
[TBL] [Abstract][Full Text] [Related]
36. The role of personality in the course of health-related quality of life and disease-specific health status among colorectal cancer survivors: A prospective population-based study from the PROFILES registry.
Husson O; Vissers PA; Denollet J; Mols F
Acta Oncol; 2015 May; 54(5):669-77. PubMed ID: 25752968
[TBL] [Abstract][Full Text] [Related]
37. Yoga for cancer survivors with chemotherapy-induced peripheral neuropathy: Health-related quality of life outcomes.
Zhi WI; Baser RE; Zhi LM; Talukder D; Li QS; Paul T; Patterson C; Piulson L; Seluzicki C; Galantino ML; Bao T
Cancer Med; 2021 Aug; 10(16):5456-5465. PubMed ID: 34213086
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.
Kanzawa-Lee GA; Knoerl R; Donohoe C; Bridges CM; Smith EML
Semin Oncol Nurs; 2019 Jun; 35(3):253-260. PubMed ID: 31053396
[TBL] [Abstract][Full Text] [Related]
39. Disease burden and pain in obese cancer patients with chemotherapy-induced peripheral neuropathy.
Cox-Martin E; Trahan LH; Cox MG; Dougherty PM; Lai EA; Novy DM
Support Care Cancer; 2017 Jun; 25(6):1873-1879. PubMed ID: 28124735
[TBL] [Abstract][Full Text] [Related]
40. Emotional distress and quality of life during folinic acid, fluorouracil, and oxaliplatin in colorectal cancer patients with and without chemotherapy-induced peripheral neuropathy: A cross-sectional study.
Hsu HT; Wu LM; Lin PC; Juan CH; Huang YY; Chou PL; Chen JL
Medicine (Baltimore); 2020 Feb; 99(6):e19029. PubMed ID: 32028414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
